Experimental therapy could save lives from sepsis

A terapia experimental podia conservar vidas do sepsis

por Brendon Nafziger, DOTmed News Associate Editor | August 04, 2010

And though research is ongoing for anti-PD-1 therapies for cancer, it still might be some time before it reaches clinical trials for helping against sepsis. Opal believes many biotechnology and pharmaceutical companies have been burned by "spectacular failures" in sepsis research.

"We have to convince companies it’s still a viable market," he said. "I don’t wish to suggest there are not obstacles -- there certainly are. But I think the advantage of this strategy, is it's a new way of looking at treatment."

Ensure critical devices are ready to go

Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.